Article Versions Notes

Fanini F, Bandini E, Plousiou M, Carloni S, Wise P, Neviani P, Murtadha M, Foca F, Fabbri F, Vannini I, et al. MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2021; 22(24):13357. https://doi.org/10.3390/ijms222413357

Fanini, Francesca, Erika Bandini, Meropi Plousiou, Silvia Carloni, Petra Wise, Paolo Neviani, Mariam Murtadha, Flavia Foca, Francesco Fabbri, Ivan Vannini, and et al. 2021. "MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 22, no. 24: 13357. https://doi.org/10.3390/ijms222413357

Fanini, F., Bandini, E., Plousiou, M., Carloni, S., Wise, P., Neviani, P., Murtadha, M., Foca, F., Fabbri, F., Vannini, I., & Fabbri, M. (2021). MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 22(24), 13357. https://doi.org/10.3390/ijms222413357